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Copolymer poly (DL-lactide-co-glycolide) (PLGA) is extensively investigated for various biomedical applications such as controlled
drug delivery or carriers in the tissue engineering. In addition, zinc oxide (ZnO) is widely used in biomedicine especially for
materials like dental composites, as a constituent of creams for the treatment of a variety of skin irritations, to enhance the
antibacterial activity of differentmedicaments and so on.Uniform, spherical ZnOnanoparticles (nano-ZnO) have been synthesized
via microwave synthesis method. In addition to obtaining nano-ZnO, a further aim was to examine their immobilization in
the PLGA polymer matrix (PLGA/nano-ZnO) and this was done by a simple physicochemical solvent/nonsolvent method. The
samples were characterized by X-ray diffraction, scanning electron microscopy, laser diffraction particle size analyzer, differential
thermal analysis, and thermal gravimetric analysis. The synthesized PLGA/nano-ZnO particles are spherical, uniform, and with
diameters below 1 𝜇m. The influence of the different solvents and the drying methods during the synthesis was investigated too.
The biocompatibility of the samples is discussed in terms of in vitro toxicity on human hepatoma HepG2 cells by application of
MTT assay and the antimicrobial activity was evaluated by brothmicrodilutionmethod against different groups of microorganisms
(Gram-positive bacteria, Gram-negative bacteria, and yeast Candida albicans).
1. Introduction
Recently, significant effort has been dedicated to develop
micro- and nanoparticles for drug delivery since they offer
an appropriate means to distribute the therapeutically active
drug molecule only to the site of action, without affecting
healthy organs and tissues [1–3]. Many different polymers,
both synthetic and natural, have been employed in making
biocompatible and biodegradable nanoparticles. Polyesters
micro- and nanoparticles are used for the controlled delivery
of different classes of active substances such as anticancer
agents, growth factors, antibiotics, antimicrobial agents,
metal, and metal oxide nanoparticles [4–8]. Polyester, poly
(DL-lactide-co-glycolide) (PLGA), is a copolymer approved
by Food and Drug Administration (FDA) for medical and
pharmaceutical applications. Physicochemical properties of
nanoparticles which include small size and very large specific
surface area significantly improve their bioavailability and
minimize drug toxicity. Inorganic antibacterial nanoparticles
especially offer some unique benefits in overcoming major
problems related to treatment process such as reducing
dosage of antibacterial agent, minimizing side effects, over-
coming bacterial resistance, and lowering overall cost of the
fabrication process [7, 8].
ZnO represents a multifunctional material with a wide
and direct band gap energy of 3,37 eV. Besides its extraor-
dinary optical, catalytic, semiconducting, and piezoelec-
tric properties, ZnO is a promising material for a variety
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of biological applications because of its chemical stability,
antimicrobial activity, high biocompatibility, and nontoxicity
to human cells [9, 10]. Also, zinc is a mineral element
essential to human health and used in the form of ZnO in
the daily supplement for zinc. As a consequence of previously
mentioned properties ZnO nanoparticles can be used for
cellular imaging [9, 10], biodetection [11], drug delivery [12,
13], and various kinds of therapy [14, 15]. ZnO has a wide
range of different nanostructures already used in numerous
commercial products such as sunscreen products, different
types of sensors, industrial coatings, and antibacterial agents
[16]. Particularly ZnO nanoparticles show a wide range of
antibacterial activities towards Gram-positive and Gram-
negative bacteria, including a major food borne pathogens
attributed to the generation of reactive oxygen species (ROS)
on this oxide surfaces. In recent years, much attention has
been paid to preparation of organic/nanosized inorganic-
particles composite materials for a various types of appli-
cations especially in medicine and pharmacy [7, 17]. For
example, inorganic core-polymer shell hybrid microspheres
have attracted attention because the materials can reveal
special characteristics, such as improved strength, shape,
and chemical resistance [18]. Above all, the properties of
nanocomposites are greatly influenced by both the dispersing
degree of nanoparticles in the base polymers and the interfa-
cial adhesion between the inorganic and organic components
[19]. Although nanocomposites can be prepared by simply
mixing of nanoparticles with base polymers, the dispersing
degree of nanoparticles and the interfacial linkage were obvi-
ously insufficient to obtain desirable material properties [20].
In previous studies, ZnO was incorporated in variety of
different polymers such as poly (methyl methacrylate) [21,
22], polystyrene [23, 24], polyamide [25], polyacrylonitrile
[26], and polyurethane [27, 28] and the results have shown
that the prepared polymer/ZnO composites presented better
performances compared to the polymers alone. All of these
composite materials were prepared in the forms of films,
scaffolds, fibers, or grafts [29, 30]. For the preparation of these
polymer/ZnO composites different methods were applied
such as dissolution [31], microemulsion polymerization [24],
sonication [32], or spin coating method [33].
Our study thus reports on obtaining innovative PLGA
nanocomposite spheres with immobilized nano-ZnO
(PLGA/nano-ZnO), which represent an important system in
the field of medicine, pharmacy, and controlled drug delivery
and in particular to prevent infections. The samples were
characterized by X-ray diffraction (XRD), scanning electron
microscopy (SEM), laser diffraction particle size analyzer
(PSA), differential thermal analysis (DTA), and thermal
gravimetric analysis (TGA) which demonstrated the suc-
cessful immobilization of ZnO nanoparticles within PLGA
polymer matrix. Controlling the morphology of micro- and
nanoparticles is essential for exploiting their properties for
their utilization in different technologies. Therefore, in this
study we have examined influence of different solvents as well
asmethod of drying on themorphology of PLGA/nano-ZnO.
Further, in order to evaluate the in vitro cytotoxic potential of
as prepared ZnO as well as PLGA/nano-ZnO, we used a test
system with human hepatoma cells, HepG2. This was done
by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay. The antimicrobial activities of ZnO
as well as PLGA/nano-ZnO were evaluated by broth microd-
ilution method against the Gram-positive bacteria Staph-
ylococcus aureus (ATCC 25923), Staphylococcus epidermidis
(ATCC 12228), and Bacillus subtilis (ATCC 6633) and the
Gram-negative bacteria Escherichia coli (ATCC 25922),
Klebsiella pneumoniae (ATCC 13883), Salmonella abony
(NTCT – 6017) and Pseudomonas aeruginosa (ATCC 27853),
and the yeast Candida albicans (ATCC 24433).
2. Materials and Methods
2.1. Materials. Poly (DL-lactide-co-glycolide) (PLGA)
was obtained from Durect, Lactel, Adsorbable Polymers
International and had lactide to glycolide ratio of 50 : 50.
Molecular weight of polymer was 40000–50000 g/mol.
Polyvinylpyrrolidone (PVP), zinc acetate dihydrate
(Zn(CH3COO)2⋅2H2O), and sodium hydroxide (NaOH)
were obtained fromMerck Chemicals Ltd. (Merck, Germany).
All chemicals and solvents were of reagent grade.
2.2. Methods
2.2.1. Synthesis of ZnO Nanoparticles. ZnO nanoparticles
were prepared via microwave assisted synthesis method
as previously described, but with modifications
[34]. Starting chemicals were zinc acetate dihydrate
(Zn(CH3COO)2⋅2H2O) and sodium hydroxide (NaOH). In
the synthesis procedure 1.75M solution of NaOH was slowly
added into a 0.07mol solution of Zn(CH3COO)2 2H2O
at permanent temperature of 60∘C and under continuous
stirring at 1000 rpm. The white precipitate was formed,
indicating enactment of a chemical reaction.The as prepared
suspension was treated in a microwave field through 5min
time period. Strength of the applied microwave field was
150W. Final reaction product was cooled to the room
temperature and then centrifuged at 8000 rpm for 10min
to obtain white precipitate. Synthesized ZnO powder was
washed out several times with absolute ethanol and deionized
water and dried at 60∘C for couple hours.
2.2.2. Synthesis of PLGA/Nano-ZnO Particles with Acetone as
Solvent and Ethanol as Nonsolvent. PLGA/nano-ZnO parti-
cles were synthesized by physicochemical solvent/nonsolvent
method. Immobilization of ZnO nanoparticles into PLGA
polymer matrix was performed using a homogenization
process of water and organic phase (Figure 1). Firstly, 200mg
of PLGA was dissolved in 10mL of acetone. This solution
was constantly mixed on a magnetic stirrer for about 15min
and at room temperature. Thereafter, 1mL of the ZnO
dispersion in acetone (0.55%w/w) was added dropwise into a
PLGA/acetone solution while constantly being homogenized
at 1200 rpm for 30min.This was followed by precipitation by
addition of 15mL ethanol, with the solution obtained being
poured very slowly into 40mL aqueous 0.05% (w/w) PVP
solution, with continuous stirring at 1200 rpm. PVP was used
as a stabilizer in order to prevent particles agglomeration.
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Figure 1: Scheme for preparation of PLGA/nano-ZnO particles.
Finally, the prepared PLGA/nano-ZnO dispersion was
decanted and left overnight to dry at room temperature.
2.2.3. Synthesis of PLGA/Nano-ZnO Particles with Ethyl
Acetate as Solvent and Ethanol as Nonsolvent. In order to
examine the influence of different solvents on morphology
of PLGA/nano-ZnO particles, ethyl acetate (C4H8O2) was
used as solvent in the experiment instead of acetone. PLGA
commercial granules (200mg) were dissolved in 10mL ethyl
acetate over approximately 15min at room temperature. All
other reaction parameters were caped the same as in the
experiment described above.
2.2.4. Synthesis of PLGA/Nano-ZnO Particles Using Freeze-
Drying in the Synthesis. Freeze-drying or lyophilisation is
a method used to transform solutions of formulations into
solids of sufficient stability for distribution and storage.
Examination of the influence of freeze-drying on morphol-
ogy of PLGA/nano-ZnO particles was also part of this work.
All steps in the synthesis were the same as in the experiments
described above except that the PLGA/nano-ZnO particles
were freeze-dried. After the freezing, method of lyophilisa-
tion was utilized at −55∘C and the pressure of 0.3mbar. Main
drying was performed for 8.5 h, and final drying for 30min,
using Freeze Dryer Christ Alpha 1-2/LD plus.
2.2.5. Morphology Studies. To define the microstructure of
ZnO particles, field-emission scanning electron microscopy
(FE-SEM) analysis was carried out, on a Carl Zeiss SUPRA
35 VP instrument. The size distribution of the synthesized
samples was measured using the laser diffraction particle size
analyzer (Mastersizer 2000; Malvern Instruments Ltd.). The
size measurement range of this instrument is from 20 nm
up to 2mm. Prior to measuring, the sample was treated
for 15min in an ultrasonic bath. The morphology of the
synthesized PLGA/nano-ZnO particles was examined using
scanning electron microscopy (SEM) on JEOL JIB-4601 F
Multi Beam Platform.
2.2.6. XRD Analysis. For identification of the phase com-
position (phase analysis) of the synthesized powders, X-ray
diffraction (XRD) method was applied with a Philips PW
1050 diffractometer with Cu-K𝛼1,2 radiation. The measure-
ments were carried out in the 2𝜃 range of 10∘ to 70∘, with a
scanning step width of 0,05∘ and 2 s per step.
2.2.7. Thermal Analysis. Differential thermal analysis (DTA)
and thermal gravimetric analysis (TGA) measurements were
carried out using a SETSYS Evolution TGA-DTA/DSC
instrument (SETERAM Instrumentation, France) on pow-
dered sample PLGA/nano-ZnO of approximately 15mg.
Assigned temperature range was from room temperature to
1200∘C. The data were baseline corrected by carrying out a
blank run and subtracting this from the original data.
2.2.8. Cytotoxicity Study. The samples were evaluated for
their in vitro cytotoxicity towards human hepatoma HepG2
cells by application of MTT assay. This is a colorimetric
assay, based on the measurement of conversion of the yel-
low thiazolyl blue tetrazolium bromide (MTT) to a purple
formazan derivative by mitochondrial dehydrogenase in
viable cells. The HepG2 cells were cultured in Minimum
Essential Medium Eagle (MEM; Sigma) supplemented with
10% fetal bovine serum (FBS; Gibco), sodium bicarbonate
(1.5 g/L), sodium pyruvate (0.11 g/L), HEPES buffer (20mM),
streptomycin (0.1 g/L), and penicillin (100 000 IU/L), at 37∘C
in a humidified atmosphere containing 5% CO2. For the
experiments, the cells were seeded in 96-well plates at the
density 25 000 cells/well in 0.2mL of MEM 10% FBS and
incubated for 24 h to attach. Then, the medium was removed
and the cells were treated by samples’ dilutions at the con-
centrations 0,000001, 0,00001, 0,0001, 0,001, and 0,01%w/v,
for 24 h. Two independent experiments were conducted, and
in each experiment cells were treated in triplicates, with
control (nontreated) wells included in each plate. In each
experiment, solvent controls were also tested, in solvent
concentrations corresponding to the ones in the samples
treatments. Following incubation, medium was removed
and cells were incubated for 3 h with 0.05mg/0.1mL/well
MTT dissolved in serum-free MEM. Formazan salts were
dissolved in 0.1mL/well of 0.04M HCl in isopropanol, and
light absorption was measured using a plate reader (Thermo
Labsystems) on 540 nm, with reference wavelength 690 nm.
Cell viabilitywas expressed as a percentage of the correspond-
ing control value (100%). The data were analyzed by one-
wayANOVA, followed byDunnett’sMultiple Comparison Test
(𝑃 ≤ 0.05) using the GraphPad Prism 5 software.
2.2.9. Antimicrobial Activity. Theantimicrobial activity of the
ZnO and PLGA/nano-ZnO particles was investigated against
Gram-positive bacteria Staphylococcus aureus (ATCC 25923),
Staphylococcus epidermidis (ATCC 12228), and Bacillus sub-
tilis (ATCC6633) and theGram-negative bacteriaEscherichia
coli (ATCC 25922), Klebsiella pneumoniae (ATCC 13883),
Salmonella abony (NTCT – 6017) and Pseudomonas aerugi-
nosa (ATCC 27853), and the yeast Candida albicans (ATCC
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Figure 2: (a) Representative FE-SEM image of ZnO particles (bar 100 nm). (b) Particle size distribution profile for ZnO particles.
24433). In order to determine minimum inhibitory concen-
trations (MICs) of the prepared samples, a broth microdilu-
tion method was used. MIC represents the lowest concentra-
tion of a compound at which the microorganism does not
demonstrate visible growth. MICs were determined accord-
ing to Clinical and Laboratory Standards Institute (CLSI
2007) [35]. Tests were performed in Mu¨ller Hinton broth for
the bacterial strains and in Sabouraud dextrose broth for C.
albicans. Overnight broth cultures were prepared for each
strain, and the final concentration in each well was adjusted
to 2 × 106CFU/mL. The tested samples were dissolved in 1%
dimethylsulfoxide and diluted to the desired concentrations
(ranging from 62,5 to 1000 𝜇g/mL) in fresh Mu¨ller-Hinton
broth for bacteria and Sabouraud broth for C. albicans. In
the tests, 0.05% triphenyl tetrazolium chloride (TTC, Aldrich
Chemical Company Inc., USA) was also added to the culture
medium as a growth indicator. TTC is a redox indicator
used for differentiation between metabolically active and
nonactive cells. The colorless compound is enzymatically
reduced to red 1,3,5-triphenylformazan by cell dehydroge-
nases, indicating metabolic activity (red color of the medium
inmicrotiter plate well). As a positive control of growth, wells
containing only the microorganisms in the broth were used.
Bacteria growth was determined after 24 h, while growth of
Candida albicans was determined after 48 h of incubation
at 37∘C. All of the MIC determinations were performed in
duplicate, and two positive growth controls were included.
3. Results and Discussion
Even though the morphology of micro- and nanoparticles is
of great importance, it is generally not well characterized and
practically very hard to control. Nevertheless, this is of prime
importance. Morphological characteristics of the obtained
ZnO particles are revealed by FE-SEM and PSA. Figure 2(a)
shows nanostructured ZnO powder composed of uniform,
spherical particles with a narrow particle size distribution
and average diameter of approximately 63 nm (Figure 2(b)).
From the presented FE-SEM image (Figure 2(a)), it can
be seen that obtained ZnO powder is composed of well
dispersed nanoparticles. Particles size distribution of theZnO
nanopowder is presented in Figure 2(b). Designations 𝑑10,
𝑑50, and 𝑑90 means that 10, 50, and 90% of total number of
the measured particles have diameter less than 34 nm, 63 nm,
and 118 nm, respectively.
SEM images of PLGA/nano-ZnO particles prepared by
physicochemical solvent/nonsolvent method with acetone
as solvent and dried at room temperature are presented in
Figure 3(A). SEM analysis showed that PLGA/nano-ZnO
particles have uniform, spherical morphology, with a narrow
particle size distribution and smooth surfaces. Diameters
of the particles are of about 200 nm. In contrast to well
defined morphology of PLGA/nano-ZnO particles prepared
with acetone, PLGA/nano-ZnOparticles, preparedwith ethyl
acetate as solvent and dried at room temperature, are very
agglomerated, with no clearly defined forms and dimensions
(Figure 3(B)). Only small number of spherical, micron size
particles, with a broad particle size distribution and a smooth
surface can be seen in the sample presented in Figure 3(B).
PLGA/nano-ZnO particles prepared by physicochemical sol-
vent/nonsolvent method with acetone as solvent and freeze-
dried are presented in Figure 3(C). From these images it can
be seen that sample consisted of particles which are with
small sizes comparable with particle’s sizes of the sample
also obtained with acetone but dried at room temperature.
However particles are agglomerated. Obviously, this process
generates various stresses during freezing and desiccation
steps. The most likely reason why particles are so agglomer-
ated (Figure 3(C)) is that we did not use any cryoprotectant
in the synthesis.
Further, we have characterized ZnO and PLGA/
nano-ZnO particles prepared by physicochemical solvent/
nonsolventmethodwith acetone as solvent and dried at room
temperature. In order to determine crystal structure and
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Figure 3: (A) Representative SEM images of PLGA/nano-ZnO particles prepared with acetone and dried at room temperature (bars 0,5 𝜇m,
1 𝜇m, and 5𝜇m). (B) Representative SEM images of PLGA/nano-ZnO particles prepared with ethyl acetate and dried at room temperature
(bars 2 𝜇m, 5 𝜇m, and 5 𝜇m). (C) Representative SEM images of PLGA/nano-ZnO particles prepared with acetone and freeze-dried (bars
0,5 𝜇m, 2 𝜇m, and 5𝜇m).
phase composition of PLGA/nano-ZnO, XRD method was
applied. As it is shown in Figure 4 characteristic diffraction
peaks corresponding to a pure hexagonal wurtzite phase of
the crystalline ZnO nanostructured powder are obtained,
according to the JCPDS card number 36-145. PLGA as
an amorphous compound did not show any crystalline
diffraction peaks in the presented spectra. Broad and very
low intensity peak in the 2𝜃 range of 10 to 25∘ was observed
indicating its amorphous structure.
Figure 5(a) shows differential thermal analysis DTA
(green) and relative mass loss TGA (black) curves corre-
sponding to synthesized nanostructured ZnO powder. The
TGA curve represents the total weight loss of approximately
5 wt% due to the elimination of the residual hydroxyl groups.
The presence of the reaction precursor Zn(CH3COO)2 in the
final product can be distinguished by the three characteristic
endothermic processes that take place during heating to
350∘C. The first process which corresponds to dehydration
of zinc acetate dihydrate occurs at 𝑇1 ≈ 100
∘C, the second
represents process ofmelting of anhydrous salt at𝑇2 ≈ 250
∘C,
and the third evaporation of zinc species 𝑇3 ≈ 320
∘C. The
endothermic peak at 𝑇4 ≈ 450
∘C can be attributed to crystal-
lization process of the ZnO hexagonal crystal structure [36].
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Figure 4: XRD patterns of as prepared ZnO nanoparticles and
PLGA/nano-ZnO powder.
DTA-TGA curves (blue and red, resp.) of prepared
PLGA/nano-ZnO powder are displayed in Figure 5(b). It can
be clearly seen that the TG curve demonstrates major weight
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Figure 5: DTA-TGA curves of (a) ZnO nanoparticles and (b) PLGA/nano-ZnO particles prepared by physicochemical solvent/nonsolvent
method with acetone as solvent and dried at room temperature.
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Figure 6: Viability of HepG2 cells treated with ZnO nanoparticles or PLGA/nano-ZnO for 24 h.The data are presented as mean values of six
replicates from two independent experiments ±SEM. ∗∗: statistically significant difference compared to the control (0%w/v), 𝑃 ≤ 0.01.
loss of approximately 95wt% in the considered temperature
range. The weight loss of PLGA/nano-ZnO, attributed to
thermal decomposition of polymer, occurs in two phases
(𝑇1󸀠 ≈ 398
∘C—91. 25% and 𝑇2󸀠 ≈ 545
∘C—3. 30%). DTA
curve reveals an endothermic process at about 50∘C which
can be assigned to the relaxation peak that follows the glass
transition of the polymer. The exothermic peaks around
𝑇1 ≈ 350, 𝑇2 ≈ 400, and 𝑇3 ≈ 500
∘C are related to the
thermal decomposition of the polymer. The decomposition
process, characterized by an endothermic peak, has started at
approximately 𝑇 ≈ 320∘C [37].
For the cytotoxicity study ZnO nanoparticles and
PLGA/nano-ZnO particles prepared with acetone as solvent
and ethanol as nonsolvent, were used. In vitro cytotoxicity
of ZnO nanoparticles and PLGA/nano-ZnO was determined
with MTT assay after exposure of HepG2 cells to 0,000001,
0,00001, 0,0001, 0,001, and 0,01% v/v of ZnO nanoparticles
or of PLGA/nano-ZnO prepared with acetone for 24 h. At
the applied exposure conditions ZnO nanoparticles as well as
PLGA/nano-ZnO did not affect the viability of HepG2 cells
(Figure 6).The cell viability data for the vehicle control are not
shown in Figure 6 as they were almost identical as negative
control.
One of the aims of our study was to examine antimicro-
bial activity of ZnO and PLGA/nano-ZnO against different
groups of microorganisms (Gram-positive bacteria, Gram-
negative bacteria, and yeast Candida albicans). In order to
determine minimum inhibitory concentrations (MICs) of
the tested samples we performed broth microdilution test,
according to CLSI (2007) which is standard method [38].
Minimal inhibitory concentrations of the samples were deter-
mined against Gram-positive bacteria Staphylococcus aureus
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Figure 7: Minimal inhibitory concentrations of ZnO and PLGA/
nano-ZnO nanoparticles determined using a broth microdilution
assay against Gram-positive bacteria Staphylococcus aureus (ATCC
25923), Staphylococcus epidermidis (ATCC 12228), and Bacillus sub-
tilis (ATCC 6633) and the Gram-negative bacteria Klebsiella pneu-
moniae (ATCC 13883), Escherichia coli (ATCC 25922), Salmonella
abony (NTCT – 6017) and Pseudomonas aeruginosa (ATCC 27853),
and the yeast Candida albicans (ATCC 24433).
(ATCC 25923), Staphylococcus epidermidis (ATCC 12228),
and Bacillus subtilis (ATCC 6633) and the Gram-negative
bacteria Klebsiella pneumoniae (ATCC 13883), Escherichia
coli (ATCC 25922), Salmonella abony (NTCT – 6017) and
Pseudomonas aeruginosa (ATCC 27853), and the yeast Can-
dida albicans (ATCC 24433) (Figure 7). Generally, antimicro-
bial activity of nanoparticles has received significant interest
worldwide since many microorganisms exist in the range
from few of nanometers to tens of micrometers. One of the
explanation why particles such as ZnO display antimicrobial
activities is due to increased specific surface area as a result
of the reduction of the particle size which leads to enhanced
particle surface reactivity. Also, reactive oxygen species such
as hydrogen peroxide, hydroxyl radicals, and peroxide have
been important bactericidal and bacteriostatic factor for
several mechanisms involving cell wall damage because
of zinc oxide localized interaction, enhanced membrane
permeability, internalization of nanoparticles due to loss of
proton motive force, and so forth [39]. Results of this study
(Figure 7) provided the evidence of a considerable antibac-
terial activity of ZnO as well as PLGA/nano-ZnO against
all of the tested strains. The samples exhibited bacteriostatic
effect. Some standard antimicrobial drugs (tetracyclines and
chloramphenicol) are also, mainly, bacteriostatic, but regard-
less of this fact they are used in clinical practice. In this
case, ZnO exhibited stronger activity against Gram-positive
bacteriaBacillus subtilis (ATCC 6633) and theGram-negative
bacteria Klebsiella pneumoniae (ATCC 13883), Escherichia
coli (ATCC 25922), and Pseudomonas aeruginosa (ATCC
27853) compared to the PLGA/nano-ZnO. As it is already
mentioned above, the inorganic core-polymer shell hybrid
microspheres have attracted attention because the materials
can reveal special characteristics, such as improved strength,
shape, and chemical resistance. So far, very few studies report
success to preserve antibacterial activity when blended with
polymer [25, 40]. Here, even if there is obviously the differ-
ence between MICs of ZnO and PLGA/nano-ZnO, particles
of PLGA/nano-ZnO also showed antimicrobial properties
against eight different microbial strains. From the literature it
is known, in some cases, that improved antimicrobial activity
of ZnO can be attributed to surface defects on its abrasive
surface texture [39]. On the other hand, PLGA/nano-ZnO
particles exhibited more pronounced antimicrobial activity
against yeast Candida albicans. In the literature, different
mechanisms for the microorganism and material surface
interactions have been reported such as electrostatic and
hydrophobic forces, van der Waals forces, and adhesins such
as lectins [41]. Adhesion is an essential step for microorgan-
ism to colonize material surfaces. Previous studies described
that the adhesion should be higher on hydrophobic than
on hydrophilic material [41]. However, the strength of the
interaction between microorganism and material depends
not only on the material properties but also on the microor-
ganism surface structure itself [42]. The differences observed
for the minimum inhibitory concentrations of ZnO and
PLGA/nano-ZnO when they were evaluated versus Bacillus
subtilis, Klebsiella pneumoniae, Escherichia coli, Salmonella
abony, and Pseudomonas aeruginosa can be also explained
by differences in their cell envelopes. Most Gram-positive
cell walls contain considerable amounts of teichoic and
teichuronic acids which may account for up to 50% of the
dry weight of the wall. In addition, some Gram-positive
walls may contain polysaccharide molecules. Gram-negative
cell walls contain three components that lie outside of
the peptidoglycan layer (lipoprotein, outer membrane, and
lipopolysaccharide).The permeability of the outermembrane
varies widely from one Gram-negative species to another
[43, 44]. In accordance with this, we observed stronger
bacteriostatic activity, of tested samples, against Klebsiella
pneumoniae, Escherichia coli, and Pseudomonas aeruginosa
than against Salmonella abony. Although it would be good
that the MIC concentrations are tested also in cytotoxicity
assay, to make sure that these compounds could be used
as antimicrobial without any risk, unfortunately it was not
possible due to the limits of the experimental setup and
great solvent concentrations that could mask the compound’s
effect. However, since not a single indication of cytotoxicity
was observed for PLGA/nano-ZnO in 0.01%w/v concentra-
tion, we believe it is unlikely that 0.05–0.06%w/v would
induce significant cytotoxic response. Our assumption can
also be supported by literature data, where, for example, no
cytotoxic effects of zinc containing glasses were observed at
concentration of 0.5%w/v while MIC concentrations were
3-4 times lower [45]. All of the tested bacterial strains
may be highly resistant to traditional antibiotic therapies
[46, 47]. However, the antimicrobial mechanism is very
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complex and it is not easy to fully understand the exact
mechanismof cellmembrane damage involvedwith particles.
When immobilized in a polymer matrix, amount of filler,
interactions between filler and polymer matrix, and particle
dispersion within polymeric particles may all influence the
antimicrobial activity of the material. All of this as well as
kinetic release of ZnO from the PLGA polymer matrix will
be the subject of our next study. Also, the subject of our
future research will be to determine minimum bactericidal
concentration (MBC) and influence of different external
factors of antibacterial activity of ZnO and PLGA/nano-
ZnO against selected bacterial strains (laboratory and clinical
isolates).
4. Conclusion
Uniform, spherical ZnO particles with average diameter
of 63 nm were synthesized and then successfully immobi-
lized within a PLGA polymer matrix (PLGA/nano-ZnO).
This was confirmed by X-ray diffraction, scanning electron
microscopy, laser diffraction, differential thermal analysis,
and thermal gravimetric analysis. Influence of different sol-
vents as well as different drying methods on morphology of
PLGA/nano-ZnO particles was evaluated.The best morphol-
ogy was obtained in the case of PLGA/nano-ZnO particles
prepared by physicochemical solvent/nonsolvent method
with acetone as solvent and dried at room temperature.These
PLGA/nano-ZnO particles are spherical in shape, uniform,
and with diameters below 1𝜇m. The MTT assay data indi-
cate good biocompatibility of these ZnO and PLGA/nano-
ZnO. Both types of particles, ZnO and PLGA/nano-ZnO,
exhibited antimicrobial inhibition activity against Gram-
positive bacteria Staphylococcus aureus, Staphylococcus epi-
dermidis, andBacillus subtilis and theGram-negative bacteria
Escherichia coli,Klebsiella pneumoniae, Salmonella abony and
Pseudomonas aeruginosa, and the yeast Candida albicans.
Our data suggest that PLGA/nano-ZnO nanoparticles are
promising candidates for applications in biomedical field
since it is expected that such particles will demonstrate a
combination of desirable properties in one device, that is,
controlled drug-delivery function and prevention or elimi-
nation of possible infections.
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